A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 35/12 (2006.01)
Patent
CA 2236158
The present invention relates generally to methods for treating injury or degeneration of retinal ganglion cells by administering glial cell line- derived neurotrophic factor (GDNF). The invention relates specifically to methods for treating optic nerve injury or degeneration associated with glaucoma.
L'invention concerne des méthodes pour traiter des blessures ou des dégénérescences des cellules ganglionnaires de la rétine, en administrant un agent protéique neurotrophique obtenu de lignées de cellules gliales (GDNF). L'invention concerne plus particulièrement des méthodes pour traiter des blessures ou la dégénérescence du nerf optique provoquée par le glaucome.
Louis Jean-Claude Marcel
Yan Qiao
Amgen Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Method for treating retinal ganglion cell injury using glial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating retinal ganglion cell injury using glial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating retinal ganglion cell injury using glial... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1598621